ARCHIVES

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

July 30, 2004

Funding Opportunities: ONS Invites Applications For Instrumentation Grants on Fatigue

January 24, 1997

Funding Opportunities.

May 10, 2002

Maxine Singer Wins Top SES Award

January 8, 1988

Drug Reimbursement: Senate Bill Worse For Oncologists

July 11, 1997